Retroperitoneal @entity82 represents an @entity2416 which leads to the development of progressive @entity3041 and @entity2629 (Stewart and Friberg: Southern Medical Journal 77:1185-1187, 1984; Morad et al.: American Journal of Medicine 82:363-366, 1987). Evidence in the literature supports a hypothesis that @entity3807 represents a systemic @entity792 (Lichon et al.: Journal of Rheumatology 11:373, 374, 1984; Lipman et al.: @entity17264 196:204-206, 1966; Littlejohn and Keystone: Journal of Rheumatology 8:665-669, 1981; Katz et al.: American Journal of Clinical Pathology 67:436-439, 1977). We report a case of a @entity1 with @entity3807 , @entity3039 , presence of antinuclear antibody, and direct Coombs positivity which provides further evidence that @entity3807 is an @entity792 . @entity3551 related to his @entity82 led to bilateral @entity3041 and significant @entity8 . Also, he developed marked @entity3039 . Treatment with @entity229 produced a dramatic response in both platelet count and renal function.

Retroperitoneal XXXX accompanying @entity3039 .

@entity1 :: ('9606', 'Species') :: ['patient'] @entity3551 :: ('MESH:C536483', 'Disease') :: ['Progressive obstructive uropathy'] @entity8 :: ('MESH:D007674', 'Disease') :: ['renal function impairment'] @entity82 :: ('MESH:D005355', 'Disease') :: ['fibrosis'] @entity3807 :: ('MESH:D012185', 'Disease') :: ['retroperitoneal fibrosis'] @entity229 :: ('MESH:D011241', 'Chemical') :: ['prednisone'] @entity3041 :: ('MESH:D006869', 'Disease') :: ['hydronephrosis'] @entity2416 :: ('MESH:D054990', 'Disease') :: ['idiopathic systemic fibrosing syndrome'] @entity2629 :: ('MESH:D053099', 'Disease') :: ['azotemia'] @entity3039 :: ('MESH:D016553', 'Disease') :: ['immune thrombocytopenia'] @entity17264 :: ('50848', 'Gene') :: ['JAMA'] @entity792 :: ('MESH:D001327', 'Disease') :: ['autoimmune process']
@entity82 :: (MESH:D005355,Disease) :: ['fibrosis']
